Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30

$7.52−0.27 (-3.47%)

Close on Nov 13, 2026Market cap $102.61MP/E –Yield 0.00%

Immunic operating margin

Operating margin is operating income as a percentage of revenue.

Immunic has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?